|
Emcure Pharmaceuticals Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
33997.20 Cr.
|
P/BV
|
6.84
|
Book Value (Rs.)
|
262.35
|
|
52 Week High/Low (Rs.)
|
1769/983
|
FV/ML
|
10/1
|
P/E(X)
|
49.90
|
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
35.94
|
Div Yield (%)
|
0.17
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 6733.84 | 5779.75 |
| Total Income From Operations | 6733.84 | 5779.75 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 1274.20 | 1123.03 |
| Purchase of Traded Goods | 1735.76 | 1311.38 |
| Increase/Decrease in Stocks | -355.99 | -179.91 |
| Employees Cost | 1165.42 | 1072.93 |
| Depreciation | 308.78 | 287.29 |
| Other Expenses | 1529.45 | 1380.54 |
| Total Expenses | 5657.62 | 4995.25 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1076.22 | 784.50 |
| Other Income | 8.67 | 62.99 |
| P/L Before Interest, Excpt. Items & Tax | 1084.89 | 847.50 |
| Interest | 97.27 | 136.76 |
| P/L Before Exceptional Items & Tax | 987.62 | 710.74 |
| Exceptional Items | -41.65 | 0.00 |
| P/L Before Tax | 945.97 | 710.74 |
| Tax | 248.43 | 200.51 |
| P/L After Tax from Ordinary Activities | 697.53 | 510.23 |
| Net Profit/Loss For the Period | 697.53 | 510.23 |
| Net P/L After Minority Interest & Share Of Associates | 697.53 | 510.23 |
| | | |
| Equity Share Capital | 189.57 | 189.43 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 36.79 | 26.93 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 36.79 | 26.93 |
| | | |
| PBITOE Margin (%) | 15.98 | 13.57 |
| PBTE Margin (%) | 14.66 | 12.29 |
| PBT Margin (%) | 14.04 | 12.29 |
| PAT Margin (%) | 10.35 | 8.82 |
| PAT After MI And SOA Margin (%) | 10.35 | 8.82 |
